Fulvestrant.: Treatment of breast cancer, antiestrogen.

被引：3
|
作者：
Levin, M
D'Souza, N
Castañer, J
机构：
[1] Prous Sci, Barcelona 08080, Spain
[2] Lincoln Med & Mental Hlth Ctr, Ctr Comprehens Canc, Bronx, NY 10451 USA
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 09期
关键词：
ICI-182780; ZD-9238; Faslodex (TM);
D O I：
10.1358/dof.2001.026.09.634749
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：841 / 850
页数：10
相关论文
共 50 条
  • [1] Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant.
    Agrawal, A.
    Hannon, R. A.
    Cheung, K. L.
    Eastell, R.
    Robertson, J. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 47S - 47S
  • [2] Autocrine Human Growth Hormone (hGH) Reduces the Sensitivity of Breast Cancer Cells to Treatment with Tamoxifen and Fulvestrant.
    Perry, J. K.
    Chen, H.
    Bougen, N. M.
    Liu, D-X
    Lobie, P. E.
    CANCER RESEARCH, 2011, 71
  • [3] Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant.
    Al-Saleh, Khalid A.
    El Zawahry, Heba Mohamed
    Bounedjar, Adda
    Oukkal, Mohammed
    Saadeddin, Ahmed
    Mahfouf, Hassen
    Kamel, Bouzid
    Bensalem, Assia
    Abdel-Razeq, Hikmat
    Kandil, Alaa
    Abulkhair, Omalkhair A. M.
    Al-Foheidi, Meteb Owaish
    Ghosn, Marwan
    Boussen, Hamouda
    Haddaoui, Abderrazak
    Ayari, Jihene Braham
    Alghamdi, Mohammed
    Abdulaziz, Nashwa A.
    Kullab, Sharif Ahmed
    Nabholtz, Jean-Marc A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Fulvestrant for the treatment of advanced breast cancer
    Blackburn, Sophie A.
    Parks, Ruth M.
    Cheung, Kwok-Leung
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (07) : 619 - 628
  • [5] Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer
    Scott, Sarah M.
    Brown, Myles
    Come, Steven E.
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (05) : 819 - 826
  • [6] Correlation of CA15.3 levels with clinical response in advanced breast cancer (ABC) patients receiving fulvestrant.
    Robertson, J. F.
    Agrawal, A.
    Gutteridge, E.
    Cheung, K.
    Evans, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 38S - 38S
  • [7] Toremifene Fareston® -: Treatment of breast cancer antiestrogen
    不详
    DRUGS OF THE FUTURE, 2000, 25 (05) : 542 - 542
  • [8] NAFOXIDINE - ANTIESTROGEN FOR TREATMENT OF BREAST-CANCER
    LEGHA, SS
    SLAVIK, M
    CARTER, SK
    CANCER, 1976, 38 (04) : 1535 - 1541
  • [9] Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model
    Jelovac, D
    Macedo, L
    Goloubeva, OG
    Handratta, V
    Brodie, AMH
    CANCER RESEARCH, 2005, 65 (12) : 5439 - 5444
  • [10] Ribociclib plus fulvestrant in the treatment of breast cancer
    Neven, Patrick
    Sonke, Gabe S.
    Jerusalem, Guy
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (01) : 93 - 106
12345